Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesca M Trovato

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
International Journal of Cardiology|July 13, 2016
Echocardiography and NAFLD (non-alcoholic fatty liver disease)Francesca M Trovato, Giuseppe F Martines, Daniela Catalano, et al.
Digestive Diseases and Sciences|February 19, 2010
Protective role of coffee in non-alcoholic fatty liver disease (NAFLD)Daniela Catalano, Giuseppe Fabio Martines, Antonia Tonzuso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 9, 2015
Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashionFrancesca M Trovato, Giuseppe Fabio Martines, Daniela Brischetto, et al.
World Journal of Gastroenterology|October 31, 2014
ADV36 adipogenic adenovirus in human liver diseaseFrancesca M Trovato, Daniela Catalano, Adriana Garozzo, et al.
Journal of Clinical Gastroenterology|April 6, 2012
Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver diseaseGuglielmo M Trovato, Giuseppe Fabio Martines, Clara Pirri, et al.
American Journal of Physiology. Cell Physiology|November 5, 2020
Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19Saima Ajaz, Mark J McPhail, Keshav K Singh, et al.
Mitochondrion|January 2, 2021
Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)Saima Ajaz, Mark J McPhail, Luigi Gnudi, et al.
Diabetes Research and Clinical Practice|September 1, 2018
Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpointsAdam J Buckley, E Louise Thomas, Nader Lessan, et al.
World Journal of Hepatology|November 27, 2015
Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkersFrancesca M Trovato, Joshua M Tognarelli, Mary Me Crossey, et al.
Digestive Diseases and Sciences|September 29, 2011
Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistanceGuglielmo M Trovato, Giuseppe Fabio Martines, Francesca M Trovato, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
International Journal of Cardiology|July 13, 2016
Echocardiography and NAFLD (non-alcoholic fatty liver disease)Francesca M Trovato, Giuseppe F Martines, Daniela Catalano, et al.
Digestive Diseases and Sciences|February 19, 2010
Protective role of coffee in non-alcoholic fatty liver disease (NAFLD)Daniela Catalano, Giuseppe Fabio Martines, Antonia Tonzuso, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 9, 2015
Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashionFrancesca M Trovato, Giuseppe Fabio Martines, Daniela Brischetto, et al.
World Journal of Gastroenterology|October 31, 2014
ADV36 adipogenic adenovirus in human liver diseaseFrancesca M Trovato, Daniela Catalano, Adriana Garozzo, et al.
Journal of Clinical Gastroenterology|April 6, 2012
Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver diseaseGuglielmo M Trovato, Giuseppe Fabio Martines, Clara Pirri, et al.
American Journal of Physiology. Cell Physiology|November 5, 2020
Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19Saima Ajaz, Mark J McPhail, Keshav K Singh, et al.
Mitochondrion|January 2, 2021
Mitochondrial dysfunction as a mechanistic biomarker in patients with non-alcoholic fatty liver disease (NAFLD)Saima Ajaz, Mark J McPhail, Luigi Gnudi, et al.
Diabetes Research and Clinical Practice|September 1, 2018
Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpointsAdam J Buckley, E Louise Thomas, Nader Lessan, et al.
World Journal of Hepatology|November 27, 2015
Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkersFrancesca M Trovato, Joshua M Tognarelli, Mary Me Crossey, et al.
Digestive Diseases and Sciences|September 29, 2011
Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistanceGuglielmo M Trovato, Giuseppe Fabio Martines, Francesca M Trovato, et al.
Pageof 4